ANAPTYSBIO, INC ANAB 31.17
Health Care · NASDAQ · Data as of 2026-09-21
ANAPTYSBIO, INC (ANAB) has delivered +32.2% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1802 of 1968 stocks overall and #231 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
31.17
Overall Rank
#1802 / 1968
Sector Rank
#231 / 260
Revenue CAGR
+32.2%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio